Here are the latest quarterly results of NATCO PHARMA. For more details, see the NATCO PHARMA financial fact sheet and NATCO PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
| No. of Mths Qtr. Ending |
3
Mar-24* |
3
Jun-24* |
3
Sep-24* |
3
Dec-24* |
3
Mar-25* |
3
Jun-25* |
3
Sep-25* |
3
Dec-25* |
8-Qtr Chart Click to enlarge |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | Rs m | 10,683 | 13,626 | 13,711 | 4,748 | 12,210 | 13,289 | 13,630 | 6,473 | |
| Other income | Rs m | 420 | 481 | 638 | 1,763 | 663 | 617 | 1,000 | 581 | |
| Turnover | Rs m | 11,103 | 14,107 | 14,349 | 6,511 | 12,873 | 13,906 | 14,630 | 7,054 | |
| Expenses | Rs m | 5,710 | 5,578 | 5,668 | 4,360 | 6,729 | 7,579 | 7,838 | 4,886 | |
| Gross profit | Rs m | 4,973 | 8,048 | 8,043 | 388 | 5,481 | 5,710 | 5,792 | 1,587 | |
| Depreciation | Rs m | 555 | 441 | 458 | 470 | 983 | 576 | 524 | 462 | |
| Interest | Rs m | 62 | 52 | 41 | 44 | 102 | 32 | 131 | 95 | |
| Profit before tax | Rs m | 4,776 | 8,036 | 8,182 | 1,637 | 5,059 | 5,719 | 6,137 | 1,611 | |
| Tax | Rs m | 913 | 1,351 | 1,417 | 313 | 999 | 916 | 958 | 207 | |
| Profit after tax | Rs m | 3,863 | 6,685 | 6,765 | 1,324 | 4,060 | 4,803 | 5,179 | 1,404 | |
| Gross profit margin | % | 46.6 | 59.1 | 58.7 | 8.2 | 44.9 | 43.0 | 42.5 | 24.5 | |
| Effective tax rate | % | 19.1 | 16.8 | 17.3 | 19.1 | 19.7 | 16.0 | 15.6 | 12.8 | |
| Net profit margin | % | 36.2 | 49.1 | 49.3 | 27.9 | 33.3 | 36.1 | 38.0 | 21.7 | |
| Diluted EPS | Rs | 21.6 | 37.3 | 37.8 | 7.4 | 22.7 | 26.8 | 28.9 | 7.8 | |
| Diluted EPS (TTM) | Rs | 77.5 | 91.4 | 108.5 | 104.1 | 105.2 | 94.6 | 85.8 | 86.2 | |
Although the benchmark indices opened lower, they traded negative throughout the session and ultimately closed red.